Multiplexed HPV Lateral Flow Assay for Sensitive Point-of-Care Screening
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current HPV serological tests for HPV-associated cancers, particularly HPV16, require laboratory-based methods that are difficult to implement for large-scale serological studies and point-of-care applications, and existing point-of-care devices can only detect a single biomarker, lacking sensitivity and specificity.
Innovation Solution
Development of a multiplexed, rapid, and user-friendly fluorescent lateral flow assay using purified HPV16 E6, E7, and E2 polypeptides linked to a solid support, enabling simultaneous detection of multiple HPV-specific IgG serologic biomarkers.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Measurement precision
If laboratory-based serological tests are used for HPV detection, then sensitivity and specificity are improved, but device complexity and ease of operation deteriorate
Solution Approach 1:
The assay is divided into distinct functional zones on the test strip: sample application area, washing area with blocking buffer, detection area with HPV16 antigens (E6, E7, E2), and control area. This segmentation allows each zone to perform its specific function independently, achieving laboratory-grade sensitivity while maintaining point-of-care simplicity.
Solution Approach 2:
The test strip is pre-coated with HPV16 antigens (E6, E7, E2) and pre-loaded with washing buffer and blocking buffer in their respective zones before use. This preliminary preparation eliminates the need for complex sample preparation and reagent handling during testing, reducing device complexity while maintaining high detection precision.
2Measurement precision
If single biomarker detection is used, then device complexity is reduced, but measurement precision deteriorates
Solution Approach 1:
The test strip is designed to detect multiple HPV16 biomarkers (E6, E7, E2 antibodies) simultaneously in a single assay. The multiplexed format includes multiple detection zones, each containing specific HPV16 antigens, allowing concurrent detection of different antibodies without requiring separate tests, thereby improving detection accuracy while maintaining manageable complexity.
Solution Approach 2:
The assay transitions from detecting single biomarkers in separate tests to detecting multiple biomarkers simultaneously across different spatial zones on the same test strip. This dimensional approach allows parallel detection of E6, E7, and E2 antibodies, enhancing measurement precision through multi-parameter assessment without proportionally increasing operational complexity.
3Ease of operation
If point-of-care testing is implemented, then ease of operation is improved, but measurement precision deteriorates
Solution Approach 1:
The test strip performs self-washing and self-blocking functions through pre-loaded washing buffer and blocking buffer in designated zones. The sample flows automatically through the zones via capillary action, and the blocking buffer prevents non-specific binding without requiring manual intervention. This self-service mechanism maintains point-of-care simplicity while ensuring reliable detection through consistent washing and blocking procedures.
Solution Approach 2:
The assay replaces complex mechanical washing and blocking systems with a passive lateral flow mechanism driven by capillary action. The washing buffer and blocking buffer are delivered automatically as the sample migrates through the test strip zones, eliminating the need for manual washing steps or complex fluid handling equipment while maintaining detection reliability.
4Measurement precision
If multiple HPV antigens are detected simultaneously, then measurement precision is improved, but loss of time deteriorates
Solution Approach 1:
The lateral flow assay enables continuous detection of multiple HPV antigens (E6, E7, E2) as the sample flows sequentially through different detection zones on the test strip. All three antibodies are detected simultaneously in a single continuous flow process rather than requiring sequential testing, thereby improving diagnostic accuracy while minimizing testing duration to approximately 15 minutes.
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
The assay achieves sensitivity comparable to laboratory-based methods, allowing for rapid and cost-effective screening of HPV-associated cancers, particularly HPV16, in resource-constrained environments.
Implementation Method 1
The assay comprises: providing a subject sample; contacting the subject sample with a multiplexed lateral flow assay containing purified HPV16 E6, E7, and E2 polypeptides linked to a solid support to form a binding complex; detecting the binding complex
Implementation Method 2
contacting the subject sample with a multiplexed lateral flow assay containing purified HPV16 E6, E7, and E2 polypeptides linked to a solid support to form a binding complex; detecting the binding complex
Data Source
AI summary
Methods and compositions are provided for the detection of HPV infection in a subject sample. In particular, the methods and composition include variants of certain HPV proteins (e.g., HPV16 E6 protein), wherein the HPV proteins have been modified to enhance solubility while maintaining or enhancing seropositivity to HPV positive plasma/sera. Additional methods and compositions relate to improving purification of HPV proteins through the use of modified amino acid sequences. These approaches may enhance the performance of serological detection techniques and support broader implementation of detection assays.